FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949295893> ?p ?o ?g. }

• W2949295893 endingPage "174" @default.
• W2949295893 startingPage "170" @default.
• W2949295893 abstract "•Follow-up data on a large randomized controlled trial on juvenile idiopathic arthritis–associated uveitis (JIA-U) are presented. •Drug-induced remission of JIA-U did not persist when adalimumab was withdrawn after 1-2 years. •This study supports a longer-term role for adalimumab in the treatment of refractory JIA-U. Purpose To determine longer-term outcomes of participants enrolled from a single center in the SYCAMORE trial, a randomized placebo-controlled trial of adalimumab vs placebo in children with juvenile idiopathic arthritis–associated uveitis (JIA-U) uncontrolled on methotrexate. Design Retrospective interventional case series. Methods Medical records of all 28 SYCAMORE participants recruited at the Bristol Eye Hospital were reviewed at approximately 3-monthly intervals up to 5 years from the trial randomization date. Uveitis activity, treatment course, visual outcomes, ocular complications, and adverse events were recorded. Data are presented using summary statistics. Results Following withdrawal of the investigational medicinal product (IMP), 25 of the 28 participants were started on adalimumab for active JIA-U. Of the 12 participants in the active treatment arm of the SYCAMORE study, 11 (92%) were restarted on adalimumab after withdrawal of the IMP for active JIA-U (median time to flare 188 days [range 42-413 days). Two participants stopped adalimumab for uncontrolled JIA-U. One participant had a reduction in vision to 0.3 owing to cataract. Mean visual acuity for the remaining 27 participants was -0.04 (right eye) and -0.05 (left eye). Conclusions Drug-induced remission of JIA-U did not persist when adalimumab was withdrawn after 1-2 years of treatment. Adalimumab was well tolerated and visual acuity outcomes were excellent. To determine longer-term outcomes of participants enrolled from a single center in the SYCAMORE trial, a randomized placebo-controlled trial of adalimumab vs placebo in children with juvenile idiopathic arthritis–associated uveitis (JIA-U) uncontrolled on methotrexate. Retrospective interventional case series. Medical records of all 28 SYCAMORE participants recruited at the Bristol Eye Hospital were reviewed at approximately 3-monthly intervals up to 5 years from the trial randomization date. Uveitis activity, treatment course, visual outcomes, ocular complications, and adverse events were recorded. Data are presented using summary statistics. Following withdrawal of the investigational medicinal product (IMP), 25 of the 28 participants were started on adalimumab for active JIA-U. Of the 12 participants in the active treatment arm of the SYCAMORE study, 11 (92%) were restarted on adalimumab after withdrawal of the IMP for active JIA-U (median time to flare 188 days [range 42-413 days). Two participants stopped adalimumab for uncontrolled JIA-U. One participant had a reduction in vision to 0.3 owing to cataract. Mean visual acuity for the remaining 27 participants was -0.04 (right eye) and -0.05 (left eye). Drug-induced remission of JIA-U did not persist when adalimumab was withdrawn after 1-2 years of treatment. Adalimumab was well tolerated and visual acuity outcomes were excellent." @default.
• W2949295893 created "2019-06-27" @default.
• W2949295893 creator A5005129884 @default.
• W2949295893 creator A5015700716 @default.
• W2949295893 creator A5029898835 @default.
• W2949295893 creator A5033538873 @default.
• W2949295893 creator A5041204910 @default.
• W2949295893 creator A5060800328 @default.
• W2949295893 creator A5063975158 @default.
• W2949295893 creator A5080694922 @default.
• W2949295893 date "2019-11-01" @default.
• W2949295893 modified "2023-10-14" @default.
• W2949295893 title "Adalimumab in Juvenile Idiopathic Arthritis–Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial" @default.
• W2949295893 cites W1575205563 @default.
• W2949295893 cites W1977063092 @default.
• W2949295893 cites W2036644487 @default.
• W2949295893 cites W2067257459 @default.
• W2949295893 cites W2096903378 @default.
• W2949295893 cites W2101762349 @default.
• W2949295893 cites W2122062222 @default.
• W2949295893 cites W2154980334 @default.
• W2949295893 cites W2315850215 @default.
• W2949295893 cites W2608059792 @default.
• W2949295893 cites W2744107413 @default.
• W2949295893 cites W2778717374 @default.
• W2949295893 cites W2788360298 @default.
• W2949295893 cites W2885250711 @default.
• W2949295893 doi "https://doi.org/10.1016/j.ajo.2019.06.007" @default.
• W2949295893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31201796" @default.
• W2949295893 hasPublicationYear "2019" @default.
• W2949295893 type Work @default.
• W2949295893 sameAs 2949295893 @default.
• W2949295893 citedByCount "32" @default.
• W2949295893 countsByYear W29492958932020 @default.
• W2949295893 countsByYear W29492958932021 @default.
• W2949295893 countsByYear W29492958932022 @default.
• W2949295893 countsByYear W29492958932023 @default.
• W2949295893 crossrefType "journal-article" @default.
• W2949295893 hasAuthorship W2949295893A5005129884 @default.
• W2949295893 hasAuthorship W2949295893A5015700716 @default.
• W2949295893 hasAuthorship W2949295893A5029898835 @default.
• W2949295893 hasAuthorship W2949295893A5033538873 @default.
• W2949295893 hasAuthorship W2949295893A5041204910 @default.
• W2949295893 hasAuthorship W2949295893A5060800328 @default.
• W2949295893 hasAuthorship W2949295893A5063975158 @default.
• W2949295893 hasAuthorship W2949295893A5080694922 @default.
• W2949295893 hasBestOaLocation W29492958932 @default.
• W2949295893 hasConcept C118487528 @default.
• W2949295893 hasConcept C126322002 @default.
• W2949295893 hasConcept C141071460 @default.
• W2949295893 hasConcept C142724271 @default.
• W2949295893 hasConcept C168563851 @default.
• W2949295893 hasConcept C197934379 @default.
• W2949295893 hasConcept C204243189 @default.
• W2949295893 hasConcept C204787440 @default.
• W2949295893 hasConcept C27081682 @default.
• W2949295893 hasConcept C2776194053 @default.
• W2949295893 hasConcept C2777077863 @default.
• W2949295893 hasConcept C2777575956 @default.
• W2949295893 hasConcept C2778257484 @default.
• W2949295893 hasConcept C2780132546 @default.
• W2949295893 hasConcept C71924100 @default.
• W2949295893 hasConceptScore W2949295893C118487528 @default.
• W2949295893 hasConceptScore W2949295893C126322002 @default.
• W2949295893 hasConceptScore W2949295893C141071460 @default.
• W2949295893 hasConceptScore W2949295893C142724271 @default.
• W2949295893 hasConceptScore W2949295893C168563851 @default.
• W2949295893 hasConceptScore W2949295893C197934379 @default.
• W2949295893 hasConceptScore W2949295893C204243189 @default.
• W2949295893 hasConceptScore W2949295893C204787440 @default.
• W2949295893 hasConceptScore W2949295893C27081682 @default.
• W2949295893 hasConceptScore W2949295893C2776194053 @default.
• W2949295893 hasConceptScore W2949295893C2777077863 @default.
• W2949295893 hasConceptScore W2949295893C2777575956 @default.
• W2949295893 hasConceptScore W2949295893C2778257484 @default.
• W2949295893 hasConceptScore W2949295893C2780132546 @default.
• W2949295893 hasConceptScore W2949295893C71924100 @default.
• W2949295893 hasFunder F4320319990 @default.
• W2949295893 hasFunder F4320320045 @default.
• W2949295893 hasFunder F4320327683 @default.
• W2949295893 hasFunder F4320334736 @default.
• W2949295893 hasLocation W29492958931 @default.
• W2949295893 hasLocation W294929589310 @default.
• W2949295893 hasLocation W29492958932 @default.
• W2949295893 hasLocation W29492958933 @default.
• W2949295893 hasLocation W29492958934 @default.
• W2949295893 hasLocation W29492958935 @default.
• W2949295893 hasLocation W29492958936 @default.
• W2949295893 hasLocation W29492958937 @default.
• W2949295893 hasLocation W29492958938 @default.
• W2949295893 hasLocation W29492958939 @default.
• W2949295893 hasOpenAccess W2949295893 @default.
• W2949295893 hasPrimaryLocation W29492958931 @default.
• W2949295893 hasRelatedWork W2011992714 @default.
• W2949295893 hasRelatedWork W2026718163 @default.
• W2949295893 hasRelatedWork W2316822442 @default.
• W2949295893 hasRelatedWork W2330603297 @default.
• W2949295893 hasRelatedWork W2521793746 @default.

• next